Compound Detail
CHEMBL5281535
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5281535 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | NIXWPEDNSULKIR-DZGCQCFKSA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
386.4
MW (Da)
3.65
ALogP
7
HBA
1
HBD
85.8
PSA (Ų)
0.78
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 6.16
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Isocitrate dehydrogenase [NADP] cytoplasmic CHEMBL2007625 | IC50 | 6.16 | 5.88 | 700.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Isocitrate dehydrogenase [NADP] cytoplasmic | IC50 | = | 700.0 | nM | 6.16 | Inhibition of human N-terminal 6His-tagged IDH1 R132H mutant expressed in Escher... | 28197303 |
| Isocitrate dehydrogenase [NADP] cytoplasmic | IC50 | = | 2500.0 | nM | 5.6 | Inhibition of IDH1 R132H mutant expressed in human HCT-116 cells assessed as eff... | 28197303 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 28197303 | 10.1021/acsmedchemlett.6b00334 | Isocitrate dehydrogenase [NADP] cytoplasmic | 2 |
Data from ChEMBL 36 via Core Engine